over 50% of patients achieved 20 to 25% weight reduction thresholds at 176 weeks Semaglutide 2.4 mg: Up to 13.9% weight loss at 68 weeks Liraglutide 3.0 mg: Approximately 5.8% weight loss at 26 weeks Retatrutide (investigational triple agonist): Up to 22.1% weight loss at 48 weeks A meta-analysis of 47 randomized controlled trials confirmed a mean weight reduction of 4.57 kg, BMI reduction of 2.07 kg/m2, and waist circumference reduction of 4.55 cm versus placebo across all GLP-1 receptor agonists
For those with preserved ejection fraction (HFpEF), GLP-1 medications reduced the composite of cardiovascular death or worsening heart failure events by 32% 15
For patients who have not achieved adequate blood sugar control with oral medications alone, Ozempic injection and Tirzepatide offer promising solutions, promoting weight loss and better cardiovascular outcomes
One patient found herself eating through the medication, says Newman: She craved the emotional comfort and hadnt done enough therapy to find other ways of navigating that. In some cases, people are forced to stop GLP-1s because of intolerable side effectsand when their appetite and body size shift dramatically, they feel dysregulated and bingeing behaviors may come back in full force, Newman says
How It Works Complete a 100% online intake form covering medical history and weight-loss goals A licensed provider will review your information and will decide whether to prescribe If approved, your prescription will be sent to Embodys state-licensed sterile compounding pharmacy You can expect the medication to arrive at your door in 1-2 days The patient portal continues to provide care and will provide updates on dose changes, coaching, and support Due to the fact that everything is online and there is no required video appointment, you can expect to receive the medication within 1-2 days
doi: 10.1038/s41586-023-06956-y
.png)
